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Abstract
Background: The advent of the HIV pandemic and the more recent prevention and therapeutic interventions have
resulted in extensive and rapid changes in cause-specific mortality rates in sub-Saharan Africa, and there is demand
for timely and accurate cause-specific mortality data to steer public health responses and to evaluate the outcome
of interventions. The objective of this study is to describe cause-specific mortality trends based on verbal autopsies
conducted on all deaths in a rural population in KwaZulu-Natal, South Africa, over a 10-year period (2000-2009).
Methods: The study used population-based mortality data collected by a demographic surveillance system on all
resident and nonresident members of 12,000 households. Cause of death was determined by verbal autopsy based
on the standard INDEPTH/WHO verbal autopsy questionnaire. Cause of death was assigned by physician review
and the Bayesian-based InterVA program.
Results: There were 11,281 deaths over 784,274 person-years of observation of 125,658 individuals between Jan. 1,
2000 and Dec. 31, 2009. The cause-specific mortality fractions (CSMF) for the population as a whole were: HIV-
related (including tuberculosis), 50%; other communicable diseases, 6%; noncommunicable lifestyle-related
conditions, 15%; other noncommunicable diseases, 2%; maternal, perinatal, nutritional, and congenital causes, 1%;
injury, 8%; indeterminate causes, 18%. Over the course of the 10 years of observation, the CSMF of HIV-related
causes declined from a high of 56% in 2002 to a low of 39% in 2009 with the largest decline starting in 2004
following the introduction of an antiretroviral treatment program into the population. The all-cause age-
standardized mortality rate (SMR) declined over the same period from a high of 174 (95% confidence interval [CI]:
165, 183) deaths per 10,000 person-years observed (PYO) in 2003 to a low of 116 (95% CI: 109, 123) in 2009. The
decline in the SMR is predominantly due to a decline in the HIV-related SMR, which declined in the same period
from 96 (95% CI: 89, 102) to 45 (95% CI: 40, 49) deaths per 10,000 PYO.
There was substantial agreement (79% kappa = 0.68 (95% CI: 0.67, 0.69)) between physician coding and InterVA
coding at the burden of disease group level.
Conclusions: Verbal autopsy based methods enabled the timely measurement of changing trends in cause-specific
mortality to provide policymakers with the much-needed information to allocate resources to appropriate health
interventions.
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The advent of the HIV pandemic and the more recent
prevention and therapeutic interventions have resulted in
extensive and rapid changes in cause-specific mortality
rates in sub-Saharan Africa during the last two decades
[1-3]. South Africa, in particular, with a severe HIV epi-
demic, experienced a steep rise in adult mortality during
the 1990s and the early part of this decade [4,5] and is one
of few countries where child mortality increased from the
1990 baseline [6]. In the past few years, evidence is emer-
ging from South Africa [7,8] and elsewhere in sub-Saharan
Africa [9-12] that HIV-related mortality is declining fol-
lowing the introduction of prevention and treatment pro-
grams. In South Africa, these changes have occurred
against the backdrop of a steadily increasing noncommu-
nicable disease burden [13] and high trauma-related mor-
tality [14]. With limited reliable data as to whether HIV-
related health care is flourishing to the detriment of non-
HIV care, there is demand for timely and accurate cause-
specific mortality data to steer public health responses and
to evaluate the outcome of interventions [15].
Due to the lack of death registration systems in the
majority of the world’s poorest settings, verbal autopsy-
based mortality surveillance has become one of the meth-
ods of choice to obtain the much needed cause-specific
mortality data [15]. In particular, health and demographic
surveillance sites have a role to play in this context to
provide timely and accurate data [16]. Although South
Africa has a functioning death registration system, the
quality of cause of death data has been questioned
[17,18] and data from demographic surveillance studies
using verbal autopsies have contributed to determining
cause-specific mortality rates [19-21] in the country.
Verbal autopsy (VA) methods have traditionally
depended on physician assessment of the verbal autopsy
interview data to determine a cause of death [22], but
the efficiency, reliability, and repeatability of this
approach have recently been questioned [22,23]. Alter-
native methods to determine the cause of death on the
basis of a verbal autopsy interview have been developed
[22,24], such as the InterVA (http://www.interva.net)
system, which applies Bayes’ theorem to derive probable
causes of death from VA data [25].
Using data from a well-established longitudinal demo-
graphic surveillance, this study describes cause-specific
mortality trends based on verbal autopsies conducted on
all deaths in a rural population in KwaZulu-Natal, South
Africa, over a 10-year period (2000-2009).
Methods
Study area and population
The Africa Centre for Health and Population Studies
hosts a demographic surveillance program in the district
of Umkhanyakude in the province of KwaZulu-Natal,
South Africa [26]. Although it is largely rural, the demo-
graphic surveillance area (DSA), consisting of 435
square kilometers, also includes a township and periur-
ban informal settlements. The population is character-
ized by high HIV prevalence [27] and incidence [28],
but following the introduction of prevention of mother-
to-child transmission of HIV infection (in 2001) and
antiretroviral treatment and care (in 2004) programs,
child [8] and adult [7] all-cause mortality have started to
decline. The study population has comparatively high
levels of cardiovascular risk factors [29] and high
trauma-related mortality [30].
Mortality data
The approximately 12,000 households in the DSA were
visited thrice annually by fieldwork teams and all deaths
were notified. Upon death notification, a trained nurse
conducted an interview with the closest caregiver (par-
ent or grandparent, 26%; spouse, child, or grandchild,
25%; other relative, 20%; sibling, 14%) of the deceased
on average six months after the death. The nurses
recorded a narrative of the circumstances leading up to
the death and completed a questionnaire based on the
standard INDEPTH/WHO verbal autopsy questionnaire
[31,32]. Interviews were conducted in the local language
and transcribed by the interviewer, after verbal consent.
There were 228 (2%) refusals and 102 (0.9%) cases
where a suitable interviewee could not be identified. A
total of 13 nurses acted as interviewers over the course
of the study; 80% of the interviews were conducted by
six of these nurses. The majority of the nurses were
graduate professional nurses; the remainder had two-
year nursing diplomas. All were previously employed
with local health services and received training in
administering the verbal autopsy questionnaire.
Two methods were used to determine cause of death
for each case: physician coding and an automated
method using the InterVA v3 probabilistic verbal
autopsy interpretation model. In the physician-coded
method, two clinicians independently assigned cause of
death on the basis of the information collected during
the verbal autopsy and their clinical judgement. If con-
sensus could not be reached between the physicians, the
VA interview was refused, or no suitable interviewee
could be found, the cause of death was recorded as
“undetermined.” A third clinician reviewed all cases and
codified the causes of death using the International
Classification of Diseases, 10
th revision (ICD-10)[33].
The ICD-10 codes were mapped into global burden of
d i s e a s eg r o u p s( T a b l e1 )u s i n gt h ec r o s s w a l ki nL o p e z
[34]. A total of 27 physicians were involved over the
course of the study period (2000 to 2009) in assigning
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Page 2 of 13diagnoses, however, eight physicians were responsible
for 79% of the recorded diagnoses. Complete cause of
death coding for the physician-coded diagnoses was
available for deaths between 2000 and the end of 2008.
The InterVA model is based on Bayesian calculations
of probabilities that a particular death was due to parti-
cular causes, given a set of symptoms and circumstances
associated with the death [25]. The verbal autopsy ques-
tionnaire data were converted into the 106 input indica-
tors required by the InterVA probabilistic model using
an SQL script. Cause of death categories were obtained
by running InterVA in batch mode on the input indica-
tors with malaria prevalence set to “low” and HIV pre-
valence set to “high.” The 35 possible InterVA cause
categories were mapped to the corresponding burden-
of-disease codes to have cause categories comparable to
the physician-coded diagnoses. InterVA produced up to
three possible causes of death per case with a likelihood
value between 0 and 1 for each cause. In cases where
the likelihood values did not sum to 1 for a particular
case, the difference between the sum of the likelihood
values for the identified causes and 1 were allocated to
the “indeterminate” cause. As recommended by the
developers of InterVA, all identified causes were consid-
ered proportionate to their likelihood values in the rate
calculations.
Data analysis
Deaths and person-years of observation were aggregated
annually for the period from Jan. 1, 2000, to Dec. 31,
2009, for all individuals in the study population.
Individuals contributed to the person-years denomina-
tor from Jan. 1, 2000, or from any later date of birth or
in-migration, until Dec. 31, 2009, and they ceased to
contribute to the denominator at death, termination of
household membership, household out-migration, or the
last surveillance visit in which household membership
was confirmed. Thus, individuals who were previous
homestead residents continued to be followed when
they became nonresidents for as long as they remained
a member of (retained links with) the household under
surveillance. Out-migrants continued to be followed as
nonresident household members in 83% of emigrations
over the duration of the study.
We stratified mortality analysis by five age groups
(under 5, 5-14, 15-49, 50-64, and over 65 years). The
age-group boundaries were chosen to separate groups of
public health importance and different patterns of mor-
tality. There were no major changes in age group com-
position over the course of the study, and age-
standardized mortality rates did not differ significantly
on a year-to-year basis, therefore crude mortality rates
are reported throughout. Under-5 mortality rates were
expressed as deaths per person-years observed, rather
than the customary deaths per live births, for consistent
comparison to the mortality rates in the other age
groups. Exact Poisson confidence intervals were calcu-
lated for all-cause mortality rates and cause-specific
mortality rates and fractions where those were based on
the single-cause physician-coded causes [35]. Confidence
intervals for cause-specific mortality rates and fractions
in the case of the InterVA-coded causes were calculated
with R [36] using bootstrapping. Cause-specific mortal-
ity rates and fractions were based on the InterVA-deter-
mined causes unless otherwise stated. The kappa
analysis was done using STATA v11 [37].
Ethical approval for the Africa Centre Demographic
Surveillance was provided by the University of Kwa-
Zulu-Natal Bio-Medical Research Ethics Committee.
Results
Mortality
There were 11,281 deaths over 784,274 person years of
observation of 125,658 individuals between Jan. 1, 2000
and Dec. 31, 2009 (Table 2). All causes of death were
coded using InterVA; the 10,267 deaths between Jan. 1,
2000 and Dec. 31, 2008, were physician-coded as well.
All-cause age-standardized mortality (SMR) for the total
Table 1 Burden of disease groups
Cause category Abbreviation Burden of disease codes
HIV-related causes HIV-related U003, U009
Other communicable diseases Other CD U005, U007, U008, U010, U015, U016, U017, U018, U020, U033, U037, U039
Maternal, perinatal, nutritional, and
congenital causes
MPNC U042, U043, U044, U045, U047, U048, U050, U051, U052, U054, U131, U136, U139, U140, U142
Noncommunicable lifestyle-related
conditions
Lifestyle U079, U105, U106, U107, U108, U109, U110, U112, U113, U114, U116, U117, U119, U120, U121,
U122, U123
Other noncommunicable
conditions
Other NCD U059, U060, U061, U062, U063, U064, U065, U067, U068, U069, U070, U071, U072, U073, U074,
U075, U076, U077, U078, U080, U081, U082, U084, U085, U086, U087, U096, U097, U124, U125,
U130
Injuries Injuries U148, U150, U151, U152, U153, U154, U155, U157, U158
Indeterminate causes Indeterminate U000, Z900, Z993, Z994, Z997, Z998, Z999
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Page 3 of 13Table 2 Person-years observed, number of deaths, and sum of InterVA likelihood values per cause of death by age
group and year
0-4 yr PYO Deaths HIV-related MPNC Injuries Lifestyle Other NCD Other CD Indeterminate
2000 9,304 185 93.7 9.2 2.4 0.3 - 40.5 38.9
2001 9,761 202 95.4 10.2 0.7 2.4 - 57.4 35.9
2002 9,969 216 87.5 13.7 5.5 - - 64.8 44.5
2003 9,806 201 71.3 4.1 1.7 1.9 - 60.3 61.8
2004 9,837 140 38.1 4.9 1.9 - - 30.0 65.1
2005 9,939 141 38.0 3.5 0.7 - - 47.6 51.1
2006 10,127 118 35.5 4.2 1.9 0.6 0.8 48.6 25.5
2007 10,508 109 36.0 3.8 2.3 0.7 - 39.9 26.3
2008 10,539 118 28.6 4.7 3.0 0.7 - 53.9 27.1
2009 10,483 102 12.2 1.0 3.2 0.5 - 50.8 34.4
5-14 yr PYO Deaths HIV-related MPNC Injuries Lifestyle Other NCD Other CD Indeterminate
2000 19,642 22 3.2 - 6.8 1.7 1.4 4.7 4.3
2001 20,723 31 13.7 - 4.5 2.6 0.1 4.6 5.5
2002 21,710 35 13.0 - 4.0 1.0 1.6 8.6 6.9
2003 22,218 41 14.2 - 10.5 2.2 0.6 2.8 10.7
2004 22,416 49 25.5 - 10.6 3.0 - 1.6 8.4
2005 22,181 38 18.1 - 6.9 2.7 - 1.3 8.9
2006 22,052 33 15.7 - 2.8 1.0 0.7 5.4 7.4
2007 22,078 27 11.8 - 4.5 0.6 - 4.7 5.5
2008 21,697 36 8.3 - 9.2 2.0 1.8 4.1 9.7
2009 21,288 22 12.9 - 3.2 0.2 - 1.6 4.1
15-49 yr PYO Deaths HIV-related MPNC Injuries Lifestyle Other NCD Other CD Indeterminate
2000 28,618 441 327.4 4.1 34.9 32.3 0.3 5.2 36.8
2001 32,154 547 394.0 2.4 56.1 30.7 2.2 9.7 52.0
2002 35,475 625 485.4 2.6 44.2 29.5 3.2 6.6 53.5
2003 37,350 701 523.1 5.8 55.2 28.1 7.2 10.2 71.5
2004 39,059 694 480.6 3.1 81.2 26.3 5.1 4.3 93.3
2005 40,277 647 438.2 5.2 60.2 29.9 7.2 6.4 100.1
2006 41,826 580 375.6 2.1 73.2 26.2 3.3 7.4 92.3
2007 43,399 624 413.2 4.7 62.3 28.5 3.4 6.9 105.1
2008 44,235 509 294.6 1.8 85.4 23.7 6.3 4.9 92.3
2009 45,236 495 274.2 4.7 73.3 26.0 6.3 6.1 104.6
50-64 yr PYO Deaths HIV-related MPNC Injuries Lifestyle Other NCD Other CD Indeterminate
2000 4,325 124 49.3 - 10.8 36.4 4.4 3.5 19.6
2001 4,433 153 62.6 - 14.2 49.2 4.3 3.9 18.9
2002 4,553 125 60.7 - 4.2 40.0 1.1 2.8 16.3
2003 4,666 159 70.0 - 8.1 46.5 8.4 2.8 23.3
2004 4,735 136 64.1 - 3.0 30.5 6.5 3.4 28.5
2005 4,714 167 84.8 - 5.9 35.6 8.2 2.7 29.8
2006 4,715 164 60.7 - 7.8 43.1 6.6 4.7 41.2
2007 4,836 169 74.2 - 5.0 41.6 3.3 2.9 41.9
2008 4,990 155 55.7 - 7.0 45.5 9.6 3.7 33.5
2009 5,152 174 62.1 - 6.8 46.7 10.8 4.2 43.5
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Page 4 of 13population changed from 139 (95% CI: 130, 148) deaths
per 10,000 person-years observed (PYO) in 2000 to a
maximum of 174 (95% CI: 165, 183) in 2003 and then
declined to 116 (95% CI: 109, 123) in 2009 (Figure 1).
HIV-related causes were responsible for 50% of the
deaths over the period from 2000 to 2009, followed by
indeterminate causes at 18% and lifestyle-related non-
communicable diseases at 15% of all deaths. HIV-related
causes were responsible for a maximum 56% of deaths
in 2002, declining to a minimum of 39% of deaths in
2009. Indeterminate causes were responsible for a mini-
mum of 14% of deaths during 2000, rising to a maxi-
mum of 25% in 2009.
The largest proportion (52%) of deaths occurred in the
15-49 age group followed by the 65 and older age group
at 18%. The under-5 age group contributed 20% of the
deaths in 2000, but this declined to between 9% and
11% from 2007 to 2009. Overall, 82% of all deaths
Table 2 Person-years observed, number of deaths, and sum of InterVA likelihood values per cause of death by age
group and year (Continued)
65+ yr PYO Deaths HIV-related MPNC Injuries Lifestyle Other NCD Other CD Indeterminate
2000 3,059 139 28.4 1.6 2.8 64.0 4.3 8.0 29.9
2001 3,134 196 24.8 1.9 3.6 98.3 7.7 13.4 46.3
2002 3,170 226 34.8 2.8 8.9 103.8 14.2 7.9 53.5
2003 3,187 216 31.7 1.6 5.2 102.2 12.1 12.2 51.0
2004 3,268 202 33.2 2.5 10.1 92.8 5.8 9.1 48.5
2005 3,396 198 36.0 - 6.1 74.2 15.9 8.0 57.8
2006 3,494 197 30.2 1.8 8.7 77.1 13.2 7.1 59.0
2007 3,526 229 42.6 0.7 8.8 100.6 10.1 3.8 62.4
2008 3,539 212 25.3 0.4 9.8 104.7 6.0 5.7 60.1
2009 3,474 211 28.0 1.1 5.9 100.6 10.4 3.3 61.7
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Figure 1 Contribution Of Each Cause to All-Cause Mortality By Year. (Deaths 11, 281, Person Years Observed (PYO) 784, 274).
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Page 5 of 13occurred before the age of 65 years, declining from a
high of 85% in 2000 to 79% in 2009 (Figure 2).
The under-5 all-cause SMR peaked at 217 (95% CI:
189, 245) deaths per 10,000 PYO in 2002 and then
declined rapidly to 103 (95% CI: 83,103) in 2009
(Figure 3). This is greater than a twofold decline in
mortality. HIV-related mortality (Table 3) in this age
group had a high in 2000 of 101 deaths per 10,000
PYO (95% CI: 86,115), plateaued at around 37 deaths
per 10,000 PYO between 2004 and 2007, and then
declined further to a low of 12 (95% CI: 6, 17) in 2009.
Other communicable disease SMR varied between 31
(95%: CI 22, 38) in 2004 and 65 (95% CI: 54, 76)
deaths per 10,000 PYO in 2002. Mortality due to inde-
terminate causes was high in this age group varying
around 41 deaths per 10,000 PYO and peaked around
60 deaths per 10,000 between 2003 and 2005. The
cause-specific mortality fraction (CSMF) due to HIV-
related causes declined from 51% (95% CI: 44, 58) in
2000 to 12% (95% CI: 6, 17) in 2009. As a result of the
overall decline in the mortality rate in this age group,
the CSMF for other communicable diseases increased
from 22% (95% CI: 17, 27) in 2000 to 50% (95% CI: 42,
57) in 2009. The all-cause SMR for the 5-14 age group
peaked at 22 (95% CI: 16, 28) deaths per 10,000 PYO
in 2004 and then declined to 10 (95% CI: 6, 15) in
2009 (Figure 4).
T h ea l l - c a u s eS M Rf o rt h e1 5 - 4 9a g eg r o u pp e a k e da t
190 (95% CI: 176, 203) deaths per 10,000 PYO in 2003
and then declined to 109 (95% CI: 100, 119) in 2009
(Figure 5). HIV-related mortality peaked in 2003 at 140
(95% CI: 135, 145) deaths per 10,000 PYO and then
declined to 61 (95% CI: 56, 65) in 2009 (Table 3). The
CSMF for HIV-related causes declined from 74% (95%
CI: 71, 78) in 2000 to 55% (95% CI: 52, 59) in 2009.
This decline in HIV-related CSMF appears to be at the
expense of an increase in indeterminate CSMF, which
increased over the same period from 8% (95% CI: 7, 10)
to 21% (95% CI: 19, 24).
There was no discernible trend in all-cause mortality
in the 50-64 age group (Figure 6). HIV-related causes
constituted the largest CSMF at 42% for the entire per-
iod, followed by lifestyle-related noncommunicable dis-
eases at 27% and indeterminate causes at 19%. There
was no significant trend in HIV-related mortality and
the highest mortality rates observed occurred in 2005
(180 (95% CI: 156, 206)) and 2007 (154 (95% CI: 129,
179)) after the introduction of an antiretroviral therapy
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Page 6 of 13(ART) program in the area in 2004 (Table 3). Lifestyle-
related noncommunicable mortality remained stable at
around 88 deaths per 10,000 PYO.
Age-standardized mortality in the over-65 age group
appeared to increase in the early part of the decade,
rising from 453 (95% CI: 377, 528) deaths per 10,000
in 2000 to a peak of 721 (95% CI: 631,812) in 2002
and plateauing off to remain stable at around 611
deaths per 10,000 PYO (Figure 7). Noncommunicable
diseases were responsible for the largest CSMF at 50%,
with lifestyle-related CSMF at 45%. Indeterminate
( 2 6 % )a n dH I V - r e l a t e d( 1 6 % )c a u s e sw e r ea l s o
important.
Comparison of physician with InterVA coding
There was substantial agreement (79% kappa = 0.68
(95% CI: 0.67, 0.69)) between physician coding and
InterVA coding at the burden of disease group level.
This agreement varied significantly among age groups
(Table 4), with the lowest agreement in the under-5 age
group (kappa = 0.44 (95% CI: 0.41, 0.47)) and the over-
65 age group (kappa = 0.50 (95% CI: 0.48, 0.52)), with
the remaining age groups around the overall agreement
level. There were no significant changes in agreement
over time (Table 5).
Discussion
Cause-specific mortality trends in the under-5 age group
and the 15-49 age group were dominated by trends in
HIV-related mortality in response to the introduction of
interventions such as preventing mother-to-child trans-
mission of HIV (PMTCT) and ART [7,8]. There were
no significant trends in other causes of mortality in
these age groups. The CSMF for HIV-related causes for
the under-5 age group (34%) for the 2002-2005 period
was higher than the value (26%) reported by Byass [20]
using InterVA (with the same set of input indicators as
used by this study) for the same period in Agincourt, a
demographic surveillance site in the Mpumalanga pro-
vince of South Africa. In the case of the 15-49 age
group, the HIV-related CSMF (72%) in this study was
also higher than the value (54%) reported for the Agin-
court site.
In the older age groups, HIV-related mortality
remained important but showed no significant decline
in the second half of the 2000-2009 period.
0
25
50
75
100
125
150
175
200
225
250
275
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
D
e
a
t
h
s
/
1
0
0
0
0
 
P
Y
O
 
HIV-related Other CD MPNC Injury Noncommunicable Indeterminate All Cause Mortality (age standardized)
Figure 3 < 5 yr Age Standardized Mortality. (Deaths 1, 531, Person Years Observed (PYO) 100, 274).
Herbst et al. Population Health Metrics 2011, 9:47
http://www.pophealthmetrics.com/content/9/1/47
Page 7 of 13Table 3 Cause-specific mortality rates by age group and year (per 10,000 person years observed)
2000 0-4 yrs (95% CI) 5-14 yrs (95% CI) 15-49 yrs (95% CI) 50-64 yrs (95% CI) 65+ (95% CI)
HIV-related 100.8 (88.1-113.9) 1.6 (0.0-3.1) 114.3 (109.1-119.5) 113.8 (89.5-137.0) 94.3 (65.6-122.2)
MPNC 8.0 (2.8-12.9) - 1.4 (0.1-2.5) - 3.9 (0.0-7.6)
Injuries 2.6 (0.0-5.2) 3.5 (1.4-5.3) 11.9 (8.2-15.6) 24.4 (9.6-36.7) 9.3 (0.0-16.8)
Lifestyle 0.3 (0.0-0.7) 0.9 (0.0-1.8) 11.1 (7.6-14.4) 83.8 (62.8-103.7) 211.2 (180.8-240.9)
Other NCD - 0.7 (0.0-1.4) 0.2 (0.0-0.5) 11.1 (2.6-18.0) 18.1 (3.8-29.5)
Other CD 45.0 (35.4-54.5) 2.4 (0.3-4.2) 1.6 (0.3-2.7) 5.5 (0.0-11.5) 22.0 (11.0-32.8)
Indeterminate 42.1 (33.7-49.1) 2.2 (1.2-3.0) 13.4 (11.1-15.6) 48.2 (35.9-59.0) 95.6 (78.0-113.6)
2001 0-4 yrs (95% CI) 5-14 yrs (95% CI) 15-49 yrs (95% CI) 50-64 yrs (95% CI) 65+ (95% CI)
HIV-related 97.7 (84.6-110.8) 6.6 (4.4-9.1) 122.9 (116.9-128.9) 143.9 (118.4-170.3) 77.3 (50.9-102.3)
MPNC 10.0 (4.1-15.2) - 0.4 (0.0-0.9) - 6.1 (0.0-12.2)
Injuries 0.7 (0.0-1.4) 2.2 (0.4-3.7) 17.2 (12.5-21.5) 31.9 (15.7-47.4) 10.3 (0.0-19.3)
Lifestyle 2.5 (0.1-4.5) 1.5 (0.0-2.7) 9.9 (6.5-12.6) 111.4 (87.4-135.0) 324.3 (283.6-365.0)
Other NCD - 0.1 (0.0-0.1) 0.8 (0.0-1.5) 9.7 (1.1-16.6) 24.4 (8.5-38.4)
Other CD 59.2 (46.6-70.2) 2.2 (0.4-3.6) 2.9 (1.0-4.6) 7.2 (0.0-12.9) 38.2 (21.3-54.6)
Indeterminate 36.9 (29.3-43.0) 2.5 (1.3-3.4) 15.9 (13.4-18.2) 41.1 (28.8-52.3) 144.8 (121.5-168.7)
2002 0-4 yrs (95% CI) 5-14 yrs (95% CI) 15-49 yrs (95% CI) 50-64 yrs (95% CI) 65+ (95% CI)
HIV-related 87.7 (74.6-101.9) 5.9 (3.6-8.3) 137.1 (132.1-142.0) 134.7 (111.5-156.7) 106.8 (73.3-138.1)
MPNC 12.8 (6.3-18.0) - 0.7 (0.0-1.5) - 8.8 (0.9-15.1)
Injuries 5.5 (1.3-9.2) 1.8 (0.0-3.4) 12.0 (8.5-15.3) 7.8 (0.0-14.3) 26.3 (9.0-41.1)
Lifestyle - 0.5 (0.0-1.0) 8.3 (5.2-10.9) 88.0 (66.2-108.8) 341.3 (298.3-388.4)
Other NCD - 0.7 (0.0-1.5) 0.9 (0.0-1.7) 2.4 (0.0-4.9) 46.9 (27.1-65.0)
Other CD 65.6 (54.5-76.9) 4.0 (1.9-5.8) 1.8 (0.4-3.0) 5.5 (0.0-10.6) 22.7 (7.9-35.8)
Indeterminate 45.0 (37.4-51.7) 3.2 (1.7-4.4) 15.3 (13.0-17.6) 36.2 (23.9-46.9) 160.3 (132.6-187.5)
2003 0-4 yrs (95% CI) 5-14 yrs (95% CI) 15-4 9 yrs (95% CI) 50-64 yrs (95% CI) 65+ (95% CI)
HIV-related 72.7 (58.6-85.8) 6.4 (3.8-8.9) 140.6 (135.7-145.5) 148.2 (123.6-172.4) 99.3 (67.9-126.6)
MPNC 4.1 (0.2-7.4) - 1.4 (0.0-2.4) - 5.0 (0.0-9.6)
Injuries 1.8 (0.0-3.5) 4.8 (2.5-7.0) 13.8 (10.4-17.1) 17.4 (3.6-27.5) 16.3 (0.8-28.0)
Lifestyle 1.9 (0.0-3.6) 0.9 (0.0-1.8) 8.3 (5.8-10.7) 105.5 (81.3-127.6) 330.0 (292.1-369.7)
Other NCD - 0.3 (0.0-0.6) 1.9 (0.6-3.1) 18.4 (7.4-28.2) 39.6 (18.2-58.8)
Other CD 61.6 (49.5-73.0) 1.3 (0.1-2.3) 2.7 (1.2-4.1) 5.0 (0.0-9.6) 31.3 (16.0-44.9)
Indeterminate 62.9 (51.6-73.0) 4.9 (2.9-6.6) 18.9 (16.6-21.1) 46.3 (36.7-55.4) 156.2 (131.2-181.2)
2004 0-4 yrs (95% CI) 5-14 yrs (95% CI) 15-49 yrs (95% CI) 50-64 yrs (95% CI) 65+ (95% CI)
HIV-related 38.7 (27.8-49.1) 11.4 (8.7-14.3) 123.8 (118.5-129.4) 130.7 (111.0-151.6) 100.9 (71.1-129.3)
MPNC 4.6 (0.3-7.9) - 0.8 (0.0-1.5) - 6.3 (0.0-11.2)
Injuries 1.9 (0.0-3.8) 4.8 (2.3-6.9) 20.1 (15.9-23.8) 6.3 (0.0-12.5) 24.2 (8.9-39.0)
Lifestyle - 1.3 (0.0-2.6) 6.8 (4.7-9.0) 71.8 (53.4-88.5) 302.2 (266.5-337.7)
Other NCD - - 1.3 (0.3-2.2) 13.8 (4.3-21.7) 18.4 (4.7-30.4)
Other CD 30.5 (23.0-38.9) 0.7 (0.0-1.4) 1.0 (0.2-1.7) 5.2 (0.0-9.4) 19.8 (8.0-29.9)
Indeterminate 66.6 (55.9-76.7) 3.6 (1.8-5.2) 23.9 (20.5-27.2) 59.6 (45.6-72.5) 146.1 (122.4-169.3)
2005 0-4 yrs (95% CI) 5-14 yrs (95% CI) 15-49 yrs (95% CI) 50-64 yrs (95% CI) 65+ (95% CI)
HIV-related 38.3 (29.5-46.9) 8.2 (5.3-10.9) 108.9 (103.7-114.6) 179.4 (154.0-201.9) 104.3 (74.4-131.6)
MPNC 3.6 (0.2-6.3) - 1.2 (0.3-2.0) - -
Injuries 0.7 (0.0-1.4) 3.1 (1.1-5.0) 14.5 (11.0-17.5) 12.5 (2.0-21.0) 17.8 (3.9-30.0)
Lifestyle - 1.2 (0.0-2.4) 7.9 (5.3-10.2) 78.7 (59.2-97.4) 232.4 (199.1-264.9)
Other NCD - - 1.8 (0.8-2.7) 17.6 (5.7-27.3) 52.3 (30.9-73.2)
Other CD 47.9 (38.7-57.3) 0.6 (0.0-1.2) 1.5 (0.5-2.4) 4.0 (0.0-7.4) 17.8 (4.6-27.8)
Indeterminate 51.4 (43.0-58.6) 4.0 (2.1-5.9) 24.8 (21.2-27.9) 62.1 (46.8-76.9) 158.3 (130.4-183.0)
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Page 8 of 13Noncommunicable-disease mortality increased with
increasing age and was the major cause of death in the
65-and-older age group. There were no clear trends in
noncommunicable disease mortality over time.
The proportions of indeterminate causes in this study
for the different age groups were generally lower than
the levels reported by Byass [20] for the Agincourt site,
with the exception of the under-5 age group. In the
under-5 age group, 32% in this study compared to 26%
in the Byass study; 21% in this study compared to 38%
in the Byass study in the 5-14 age group; 12% in this
study compared to 26% in the Byass study in the 15-49
age group; 17% in this study compared to 31% in the
Byass study in the 50-64 age group, and 25% in this
study compared to 33% in the Byass study in the 65-
and-older age group.
The verbal autopsy questionnaire was not designed
from inception with the InterVA input indicators in
mind. A number (18 out of 106 indicators) did not map
directly to the questionnaire and had to be derived
indirectly. Data quality in relation to the InterVA input
indicators could not be monitored on an ongoing basis
and some of the changes over time in the indetermi-
nate-cause proportion could reflect data-quality issues.
Conclusions
There has been a substantial decline in proportion of
deaths due to HIV-related causes in the under-5 age
group over the study period coupled with a fairly con-
stant mortality rate due to other communicable diseases
and indeterminate causes. This would indicate that
further gains in reducing under-5 mortality would
Table 3 Cause-specific mortality rates by age group and year (per 10,000 person years observed) (Continued)
2006 0-4 yrs (95% CI) 5-14 yrs (95% CI) 15-49 yrs (95% CI) 50-64 yrs (95% CI) 65+ (95% CI)
HIV-related 35.1 (26.2-42.8) 7.1 (5.0-9.5) 89.8 (84.8-95.0) 126.8 (104.5-149.4) 86.8 (57.1-111.7)
MPNC 4.1 (0.0-7.6) - 0.5 (0.0-0.9) - 4.7 (0.0-8.7)
Injuries 1.8 (0.0-3.7) 1.3 (0.0-2.5) 16.8 (12.7-20.5) 14.9 (2.0-24.4) 24.9 (7.5-38.5)
Lifestyle 0.6 (0.0-1.2) 0.4 (0.0-1.0) 6.2 (4.2-8.1) 95.0 (74.9-114.4) 224.2 (190.7-257.3)
Other NCD 0.8 (0.0-1.6) 0.3 (0.0-0.7) 0.8 (0.0-1.4) 13.9 (4.2-21.4) 39.4 (21.0-57.1)
Other CD 47.9 (38.9-56.6) 2.5 (0.7-3.8) 1.5 (0.5-2.3) 9.5 (2.4-15.2) 18.1 (8.1-27.6)
Indeterminate 26.2 (20.5-31.8) 3.8 (1.3-5.7) 23.0 (19.9-26.2) 87.7 (73.2-102.6) 165.8 (140.4-189.7)
2007 0-4 yrs (95% CI) 5-14 yrs (95% CI) 15-49 yrs (95% CI) 50-64 yrs (95% CI) 65+ (95% CI)
HIV-related 34.3 (25.1-42.8) 5.4 (3.3-7.5) 95.4 (91.1-100.3) 153.4 (130.8-177.3) 116.3 (85.5-144.9)
MPNC 3.0 (0.0-5.5) - 1.4 (0.2-2.3) - 2.0 (0.0-4.3)
Injuries 2.2 (0.0-4.1) 2.0 (0.4-3.5) 13.7 (10.4-16.8) 10.4 (1.1-18.1) 24.1 (10.0-36.3)
Lifestyle 0.7 (0.0-1.5) 0.3 (0.0-0.6) 6.4 (4.3-8.4) 88.9 (66.7-109.4) 296.1 (261.9-328.5)
Other NCD - - 0.8 (0.1-1.4) 5.6 (0.0-10.1) 29.5 (14.4-42.7)
Other CD 38.6 (29.9-47.2) 2.1 (0.2-3.7) 1.6 (0.6-2.5) 4.3 (0.0-8.2) 8.3 (1.3-14.3)
Indeterminate 25.1 (19.9-30.4) 2.5 (0.8-3.9) 24.5 (20.9-27.5) 86.9 (68.2-103.5) 173.3 (144.5-199.4)
2008 0-4 yrs (95% CI) 5-14 yrs (95% CI) 15-49 yrs (95% CI) 50-64 yrs (95% CI) 65+ (95% CI)
HIV-related 27.1 (18.5-35.7) 3.8 (1.6-6.0) 66.9 (62.4-72.1) 111.7 (89.1-134.3) 70.5 (46.9-93.4)
MPNC 4.4 (0.5-7.6) - 1.0 (0.1-1.8) - 0.3 (0.0-0.7)
Injuries 2.8 (0.0-5.1) 4.2 (1.9-6.4) 18.7 (14.7-22.4) 14.7 (2.1-24.6) 27.7 (10.8-41.2)
Lifestyle 0.7 (0.0-1.5) 0.9 (0.0-1.9) 5.3 (3.4-7.1) 96.7 (77.8-116.4) 295.6 (260.9-333.1)
Other NCD - 1.1 (0.0-2.1) 1.6 (0.6-2.5) 19.8 (6.3-30.2) 19.7 (6.8-31.1)
Other CD 51.2 (42.8-60.0) 1.7 (0.2-3.0) 1.0 (0.1-1.8) 7.5 (0.0-13.6) 14.5 (4.9-23.1)
Indeterminate 25.8 (19.4-31.5) 4.8 (2.8-6.5) 20.5 (17.5-23.3) 60.3 (44.7-74.0) 173.6 (145.9-197.4)
2009 0-4 yrs (95% CI) 5-14 yrs (95% CI) 15-49 yrs (95% CI) 50-64 yrs (95% CI) 65+ (95% CI)
HIV-related 11.7 (6.2-16.7) 5.6 (3.6-7.7) 58.3 (53.9-62.3) 114.9 (94.5-137.2) 78.3 (51.7-103.4)
MPNC 0.9 (0.0-2.1) - 1.2 (0.2-2.1) - 3.1 (0.0-6.2)
Injuries 3.0 (0.0-5.7) 1.5 (0.0-2.9) 15.4 (11.7-18.9) 12.3 (1.6-20.9) 15.7 (2.6-27.0)
Lifestyle 0.4 (0.0-0.9) 0.1 (0.0-0.2) 5.3 (3.3-7.0) 94.5 (74.9-113.8) 285.8 (249.9-322.0)
Other NCD - - 1.5 (0.4-2.3) 20.6 (8.4-30.6) 29.2 (14.4-42.9)
Other CD 45.2 (38.2-52.2) 0.8 (0.0-1.5) 1.1 (0.2-1.8) 6.2 (0.3-11.0) 9.6 (0.9-16.9)
Indeterminate 36.1 (29.0-44.0) 2.3 (1.0-3.5) 26.9 (23.7-30.1) 89.4 (70.0-106.1) 185.6 (157.9-212.9)
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Figure 4 5-14 yr Age Standardized Mortality. (Deaths 333, Person Years Observed (PYO) 216, 005).
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Figure 5 15-49 yr Age Standardized Mortality. (Deaths 5, 863, Person Years Observed (PYO) 387, 630).
Herbst et al. Population Health Metrics 2011, 9:47
http://www.pophealthmetrics.com/content/9/1/47
Page 10 of 130
50
100
150
200
250
300
350
400
450
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
D
e
a
t
h
s
/
1
0
0
0
0
 
P
Y
O
 
HIV-related Other CD MPNC Injury Lifestyle Other NCD Indeterminate All Cause Mortality (age standardized)
Figure 6 50-64 yr Age Standardized Mortality. (Deaths 1, 526, Person Years Observed (PYO) 47, 118).
0
100
200
300
400
500
600
700
800
900
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
D
e
a
t
h
s
/
1
0
0
0
0
 
P
Y
O
 
HIV-related Other CD MPNC Injury Lifestyle Other NCD Indeterminate All Cause Mortality (age standardized)
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Page 11 of 13require investigation of causes other than HIV and pos-
sibly changes in public health services. Further research
is required to determine whether the resilience to
change in other communicable disease mortality is due
to interaction between interventions aimed at HIV and
those aimed at other causes of child mortality, or due to
unrelated factors.
In the 15-49 age group, the positive impact of HIV-
related interventions was substantial. We did not
explore sex-specific mortality, but given the different
age pattern in HIV prevalence [27], one would expect
some differences in the sex-specific HIV-related mortal-
ity trends. Although trauma mortality is dwarfed by
HIV-related mortality in this age group, it is still consid-
erably higher than the global mortality estimate [38].
In the older age groups, the dual burdens of commu-
nicable and noncommunicable diseases were evident.
The lack of a substantial decline in HIV-related mortal-
ity in those over 50 years old requires further investiga-
tion to determine whether this was due to lack of access
or response to treatment programs or an artifact of
competing risks from other mortality causes.
The InterVA verbal autopsy program performed well,
and the conclusions based on InterVA mortality cause
allocation would have been no different had they been
based on physician mortality cause allocation. The
InterVA program allowed more timely analysis of cause-
specific mortality; as a result we could include the 2009
deaths in this analysis in spite of the fact that physician
coding is not yet complete for 2009.
Verbal autopsy based methods enabled the timely
measurement of changing trends in cause-specific mor-
tality to provide policymakers with the much-needed
information to allocate resources to appropriate health
interventions.
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